How mature is your Data & AI organization?Take the diagnostic
All use cases

AI USE CASE

AI-Guided Personalized Treatment Recommendations

Helps clinicians select optimal, evidence-based treatment plans using patient data and genomic profiles.

Typical budget
€150K–€600K
Time to value
36 weeks
Effort
24–72 weeks
Monthly ongoing
€8K–€30K
Minimum data maturity
advanced
Technical prerequisite
ml team
Industries
Healthcare
AI type
classification, deep learning, nlp

What it is

This use case applies machine learning and deep learning to integrate patient history, genomic data, lab results, and population-level outcomes to surface personalized treatment recommendations at the point of care. Clinicians can expect to reduce time-to-optimal-therapy by 20–40% in complex cases, and studies in oncology contexts suggest 15–25% improvement in treatment response rates when genomic-guided protocols are followed. The system acts as a decision-support layer, not a replacement for clinical judgment, flagging contraindications and evidence-based alternatives. Successful deployments typically require structured EHR data, curated clinical knowledge bases, and regulatory validation.

Data you need

Structured EHR records including diagnosis history, lab results, medications, treatment outcomes, and ideally genomic or molecular profiling data per patient.

Required systems

  • erp
  • data warehouse

Why it works

  • Engage clinicians and clinical informaticists as co-designers from day one to ensure workflow integration.
  • Establish a rigorous validation and clinical governance framework before any live patient interaction.
  • Start with a narrow therapeutic area (e.g., oncology or cardiology) rather than a broad deployment.
  • Maintain a continuous feedback loop where clinicians flag incorrect or overridden recommendations to retrain the model.

How this goes wrong

  • Insufficient or poorly standardised EHR data makes model training unreliable and recommendations unsafe.
  • Regulatory approval (CE marking, FDA clearance) delays or blocks clinical deployment entirely.
  • Clinician distrust or alert fatigue causes the system to be systematically ignored after rollout.
  • Genomic data availability is too sparse in the patient population to drive meaningful personalisation.

When NOT to do this

Do not deploy this in a hospital that lacks structured, longitudinal EHR data and a dedicated clinical AI governance committee — the liability and safety risks outweigh any potential benefit.

Vendors to consider

Sources

This use case is part of a larger Data & AI catalog built from 50+ enterprise transformation programs. Take the free diagnostic to see how it ranks against your specific context.